Plant-Based Production of Recombinant Plasmodium Surface Protein Pf38 and Evaluation of its Potential as a Vaccine Candidate

Monoclonal tobacco cell lines with enhanced recombinant protein yields can be generated from heterogeneous cell suspension cultures by flow sorting

(2012) Janina Kirchhoff et al.   PLANT BIOTECHNOLOGY JOURNAL

Antibodies to plant-producedPlasmodium falciparumsexual stage protein Pfs25 exhibit transmission blocking activity

(2011) Christine E. Farrance et al.   Human vaccines & immunotherapeutics

Is vaccine the magic bullet for malaria elimination? A reality check

(2011) Roma Chilengi et al.   MALARIA JOURNAL

Population genetic analysis of the Plasmodium falciparum 6-cys protein Pf38 in Papua New Guinea reveals domain-specific balancing selection

(2011) John C Reeder et al.   MALARIA JOURNAL

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children

(2011) Sabine Bélard et al.   PLoS One

Advances and challenges in malaria vaccine development

(2010) Peter D. Crompton et al.   JOURNAL OF CLINICAL INVESTIGATION

Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control?

(2010) Hilary Ranson et al.   TRENDS IN PARASITOLOGY

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon

(2010) Benjamin Mordmüller et al.   VACCINE

Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007

(2010) Simon I. Hay et al.   PLOS MEDICINE

Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies

(2010) Jamie T. Griffin et al.   PLOS MEDICINE

Erythrocyte invasion and functionally inhibitory antibodies in Plasmodium falciparum malaria

(2009) Kristina E.M. Persson   ACTA TROPICA

Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia

(2009) Karen I Barnes et al.   MALARIA JOURNAL

Do we still need a malaria vaccine?

(2009) B. GREENWOOD et al.   PARASITE IMMUNOLOGY

Transient co-expression for fast and high-yield production of antibodies with human-likeN-glycans in plants

(2009) Louis-P. Vézina et al.   PLANT BIOTECHNOLOGY JOURNAL

pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants

(2009) Frank Sainsbury et al.   PLANT BIOTECHNOLOGY JOURNAL

Prospective Identification of Malaria Parasite Genes under Balancing Selection

(2009) Kevin K. A. Tetteh et al.   PLoS One

Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family

(2009) Jeison García et al.   VACCINE

Functional Analysis of the Leading Malaria Vaccine Candidate AMA-1 Reveals an Essential Role for the Cytoplasmic Domain in the Invasion Process

(2009) Moritz Treeck et al.   PLoS Pathogens

Malaria vaccines: a toy for travelers or a tool for eradication?

(2008) Blaise Genton   Expert Review of Vaccines

A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in Rabbits

(2008) E. J. Remarque et al.   INFECTION AND IMMUNITY

Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans

(2007) Thomas Rademacher et al.   PLANT BIOTECHNOLOGY JOURNAL